Human Peripheral Blood CD3+ T Cells
Price range: $850.00 through $1,889.00
MileCell offers high-quality, purified human CD3+ pan T cells from peripheral blood, available in fresh and cryopreserved format.
CD3+ pan T cells are the total T-lymphocyte population, comprising both CD4+ helper and CD8+ cytotoxic T cell subsets in their physiological ratio. As the central mediators of cell-mediated adaptive immunity, pan T cells serve as a representative primary cell system for evaluating overall T-cell activation, proliferation, and cytokine response in immunology research and drug discovery.
MileCell's CD3+ pan T cells are isolated from peripheral blood via immunomagnetic positive or negative selection, with every lot validated for high purity, viability, and immunophenotyping by flow cytometry. Available in fresh and cryopreserved formats, they can be used in applications spanning T-cell activation assays, mixed lymphocyte reactions, cytotoxicity studies, CAR-T functional testing, and immunotoxicity screening.
Quality
- Purity: ≥90%
- Viability: ≥90%
- Mycoplasma Detection: Negative
- Microbial Testing: Negative
- Viral Screening: Negative for HBV, HIV, HCV, TP
- Ma Y, Zhang Q, Wei Z, et al. Glucose restriction reprograms lipid metabolism and enhances immunotherapy through ZNRF3-Wnt-SCD signaling axis. J Immunother Cancer. 2026;14(6):e014927. doi:10.1136/jitc-2026-014927.
- Hao, M., Hou, S., Li, W., Li, K., Xue, L., Hu, Q., Zhu, L., Chen, Y., Sun, H., Ju, C., & Zhang, C. (Year). Combination of metabolic intervention and T cell therapy via cell-surface anchor-engineering augments solid tumor immunotherapy. Science Translational Medicine. Manuscript submitted for publication.
- Liu, X., Rong, N., Tian, Z., Rich, J., Niu, L., Li, P., Huang, L., Dong, Y., Zhou, W., Zhang, P., Chen, Y., Wang, C., Meng, L., Huang, T. J., & Zheng, H. (2024). Acoustothermal transfection for cell therapy. Science Advances, 10(8), eadk1853.




